menu

HBV

Podcasts

Beyond the Mic: Exploring the Journeys of Leaders.

View All Podcasts arrow

Cholestatic Pruritus Across the Age Spectrum: What Are You Missing?

When considering cholestatic pruritus across the age spectrum, a key point to remember is that while the underlying mechanism is similar, pediatric patients often present with unique challenges in diagnosis and management due to factors like limited communication abilities, potential side effects of medications, and the need for careful dosage adjustments; additionally, older adults might have co-morbidities that complicate treatment and require a more nuanced approach to managing pruritus

Podcasts

cardImg

Viral Hepatitis – What’s Changing?

Join Dr. Paul Kwo, from Stanford Medicine, and Dr. Tatyana Kushner, from Weill Cornell Medicine, for an insightful discussion on the evolving landscape of viral hepatitis, with a focus on hepatitis B, C, and delta hepatitis. This expert-led conversation explores the path toward hepatitis elimination by 2030, highlighting the latest advances in functional cure strategies for hepatitis B—including antisense oligonucleotides, capsid inhibitors, and immune modulators—and how they may redefine long-term disease management. The session also addresses the challenges of expanding hepatitis C treatment access to underserved and high-risk populations, the potential of long-acting injectables, and the need for simplified, rapid test-and-treat models. The dialogue concludes with a thoughtful analysis of delta hepatitis screening, global treatment guidelines, and the realistic timeline for achieving a functional cure for hepatitis B. Whether you’re a hepatologist, infectious disease specialist, or public health professional, this conversation offers critical insights into the next era of viral hepatitis care and innovation.
View All Podcasts arrow

Webcasts

cardImg

HBV/HDV-ACT Connect (ADVANCING CURATIVE TREATMENTS)

Educational Webcast
cardImg

Hepatitis B and D Infection

Joseph K. Lim, MD
cardImg

HBV/HDV Hot Topics & Virtual Roundtable

Dr. Robert Wong & Expert Panelists
View All Webcasts arrow

Abstract Library

Unlocking Boundless Knowledge Through Abstracts

View All Modules arrow
alcbimg

Universal Hepatitis B Vaccination at Birth-Risks of Revising the Recommendation.

Abers Michael S (MS);Ulrich Angela K (AK);Walensky Rochelle P (RP)

alcbimg

Latent TB treatment outcomes in patients with chronic liver disease: A retrospective cohort study.

Tran Lilian (L);Shah Anand (A);Kim Eugene J (EJ);Lopiano Sofia (S);Blanchard Isabella N (IN);Nguyen Alan (A);Rutenberg David (D);Madendere Berk (B);Patrawalla Amee (A)

alcbimg

Disease burden of chronic hepatitis B and C patients in South Korea: a population-based 16-year cohort study.

Jeong Oeuk (O);Chu Changhee (C);Kim Jungyeon (J);Lee Jae Seung (JS);Park Jun Yong (JY);Lee Kyung Eun (KE);Seong Jaehyun (J);Go Min Jin (MJ)